MENU CATEGORIES

Connect with us

Submit a Tip
MENU CATEGORIES
Posts Tagged with "martin shkreli"

Martin Shkreli, known as the pharma-bro CEO of Turing Pharmaceuticals who raised the price of HIV/AIDS drug Daraprim from $13.50 to $750, joined the columbia buy sell memes Facebook group late last night. Since joining, he has made bad jokes about Barnard students, Skyped a group of students huddled around a laptop in ButCaf, alleged […]

Read More

Nothing worse than being ghosted–uh, unless it’s by your professor. Finals week is a stressful time, and once again, Bwog in Bed’s got you covered with a lovely mess of note-worthy news, cleanly study and procrastination tips, and some dank music. Bwogline: Our favorite drug-maker douchebag, Martin Shkreli, finally got arrested, but for securities and […]

Read More

Same Semester, New President!

What Should Acting President Claire Shipman's Nickname Be?

View Results

Loading ... Loading ...

Recent Comments

woohoo Ava! (read more)
Senior Wisdom: Ava Slocum
May 21, 2025
I am your biggest fan istg (read more)
Senior Wisdom: SGC
May 21, 2025
sahmaya you will be famous forever. thank you for everything you did for bwog and for being the absolute best (read more)
Senior Wisdom: Sahmaya B.
May 21, 2025
Is it just me or does sgc have more wisdom in their pinky finger than most people do in their (read more)
Senior Wisdom: SGC
May 20, 2025

Comment Policy

The purpose of Bwog’s comment section is to facilitate honest and open discussion between members of the Columbia community. We encourage commenters to take advantage of—without abusing—the opportunity to engage in anonymous critical dialogue with other community members. A comment may be moderated if it contains:
  • A slur—defined as a pejorative derogatory phrase—based on ethnicity, race, gender, sexual orientation, ability, or spiritual belief
  • Hate speech
  • Unauthorized use of a person’s identity
  • Personal information about an individual
  • Baseless personal attacks on specific individuals
  • Spam or self-promotion
  • Copyright infringement
  • Libel
  • COVID-19 misinformation